Safety of rivaroxaban in first-time users treated for deep vein thrombosis and pulmonary embolism

被引：0
|
作者：
Ruigomez, Ana [1 ]
Schink, Tania [2 ]
Voss, Annemarie [2 ]
Herings, Ron M. [3 ]
Smits, Elisabeth [3 ]
Swart-Polinder, Karin [3 ]
Balabanova, Yanina [4 ]
Brobert, Gunnar [5 ]
Rodriguez, Luis Alberto Garcia [1 ]
机构：
[1] CEIFE Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain
[2] Leibniz Inst Prevent Res & Epidemiol BIPS GmbH, Bremen, Germany
[3] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands
[4] Bayer AG, Leverkusen, Germany
[5] Bayer AB, Solna, Sweden
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：335 / 335
页数：1
相关论文
共 50 条
  • [1] Pulmonary embolism and deep vein thrombosis in eosinophilic granulomatosis with polyangiitis successfully treated with rivaroxaban
    Naito, Tomoyuki
    Hayashi, Hiroki
    Kashiwada, Takeru
    Saito, Yoshinobu
    Abe, Shinji
    Kubota, Kaoru
    Gemma, Akihiko
    RESPIRATORY MEDICINE CASE REPORTS, 2018, 25 : 33 - 35
  • [2] AN ANALYSIS OF THE EFFICACY AND SAFETY OF EDOXABAN IN COMPARISON WITH RIVAROXABAN IN THE TREATMENT OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
    van Hout, B.
    Gumbs, P. D.
    Cohen, A. T.
    Verhamme, P.
    VALUE IN HEALTH, 2016, 19 (07) : A637 - A638
  • [3] Comparative Efficacy and Safety Of Dabigatran Etexilate and Rivaroxaban For The Treatment Of Deep Vein Thrombosis and Pulmonary Embolism
    Clemens, Andreas
    Abeysinghe, Shaun
    Gonschior, Ann-Katrin
    Hoesel, Volker
    Lock, Sarah
    Wolowacz, Sorrel E.
    Woods, Mathew
    Zimovetz, Evelina
    BLOOD, 2013, 122 (21)
  • [4] Time Trends and Excess Mortality Compared to Population Controls after a First-Time Pulmonary Embolism or Deep Vein Thrombosis
    Sandblad, Katarina Glise
    Svensson, Carl Johan
    Svennerholm, Kristina
    Philipson, Jacob
    Pivodic, Aldina
    Schulman, Sam
    Tavoly, Mazdak
    THROMBOSIS AND HAEMOSTASIS, 2025, 125 (04) : 364 - 375
  • [5] Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries
    Ruigomez, Ana
    Schink, Tania
    Voss, Annemarie
    Herings, Ron M. C.
    Smits, Elisabeth
    Swart-Polinder, Karin
    Balabanova, Yanina
    Brobert, Gunnar
    Suzart-Woischnik, Kiliana
    Rodriguez, Luis Alberto Garcia
    PLOS ONE, 2024, 19 (03):
  • [6] Pulmonary embolism and deep vein thrombosis
    Goldhaber, Samuel Z.
    Bounameaux, Henri
    LANCET, 2012, 379 (9828): : 1835 - 1846
  • [7] Deep vein thrombosis and pulmonary embolism
    Fernandez-Codina, Andreu
    Pluma-Sanjurjo, Andrea
    Romero-Jaller, Katheryne
    EMERGENCIAS, 2013, 25 (02): : 147 - 147
  • [8] Deep vein thrombosis and pulmonary embolism
    Di Nisio, Marcello
    van Es, Nick
    Bueller, Harry R.
    LANCET, 2016, 388 (10063): : 3060 - 3073
  • [9] Pulmonary embolism and deep vein thrombosis
    Goldhaber, SZ
    Morrison, RB
    CIRCULATION, 2002, 106 (12) : 1436 - 1438
  • [10] COST EFFECTIVENESS ANALYSIS OF RIVAROXABAN FOR TREATMENT OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN GREECE
    Gourzoulidis, G.
    Kourlaba, G.
    Kakisis, J.
    Matsagkas, M.
    Giannakoulas, G.
    Gourgoulianis, K.
    Vassilakopoulos, T.
    Arzoumanidou, D.
    Maniadakis, N.
    VALUE IN HEALTH, 2016, 19 (07) : A554 - A554
12345